This meeting will explore the latest developments in the use of liquid biopsies for cancer diagnosis and treatment. Presentations will focus on circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) as key biomarkers that are transforming the landscape of oncology. These advancements hold the potential to improve early detection, dose selection, monitoring, prediction, and […]

This event brings together leading experts to discuss the current landscape, challenges, and innovative developments in the field. From a detailed overview of lung cancer types and existing treatments to insights into immune-oncology (IO) advancements, small molecules, antibody-drug conjugates (ADCs), and biomarkers, this gathering will be a comprehensive exploration of the complexities in lung cancer […]

A joint meeting of the CINDIS project and the MVA Oncology Network Medicon Valley Alliance (MVA) and the Consortium for Intelligent Diagnostics of Skin Cancer (CINDIS) have the pleasure of inviting you to a joint CINDIS Symposium and MVA Oncology Network meeting about non-invasive diagnosis of skin cancers. It is difficult to diagnose skin cancers […]

Medicon Valley Alliance, together with Lund University Cancer Center (LUCC) and Skåne University Hospital Comprehensive Cancer Centre (SUHCCC), has the pleasure of inviting you to the 13th MVA Oncology Network meeting. In May 2022, Skåne University Hospital was accredited as a Comprehensive Cancer Centre (CCC). This demonstrates that SUHCCC is one of Europe’s leading cancer […]

Medicon Valley Alliance together with member company Miltenyi Biotec have the pleasure to invite you to the 12th meeting of the Medicon Valley Alliance Oncology Network on the 16th of March, 2022. Immuno-oncology is sometimes referred to as the fifth pillar of cancer treatment, alongside surgery, radiotherapy, chemotherapy and precision therapy. The activation and utilization […]

Medicon Valley Alliance together with member company Ascelia Pharma have the pleasure to invite you to the 11th meeting of the Medicon Valley Alliance Oncology Network on the 24th of August, 2021. Rare disease affects a small number of patients; the European Medicines Agency defines rare disease where the prevalence of the disease is less […]

Welcome to the 10th meeting of the Medicon Valley Alliance Oncology Network on 8th of December 2020.  Medicon Valley Alliance, together with Lund University and the University of Copenhagen, has the pleasure to invite you to the 10th MVA Oncology Network meeting. This event will focus on transitioning towards personalised medicine for cancer patients by […]

  Welcome to the first webinar for the Medicon Valley Alliance Oncology Network! The MVA Oncology Network organises this webinar where AbbVie will explain  their view on external innovation and explain their partnering strategy. Until we can meet in larger groups, we have decided to bring the possibility to share experiences in a shorter webinar […]

  Welcome to the MVA Oncology Network and our 9th meeting! The future of oncology – treatments in multiple combinations. Combination therapies are upcoming within oncology R&D, but what is the right strategy for their development in the early stages? At this meeting we will look into the optimal design of early clinical trials, the […]

Welcome to MVA Oncology Network and our 8th meeting! Clinical development: Challenges, opportunities & what can we learn from each other? Finding the right treatment for the right patient is a major challenge within oncology R&D. The clinical transition phase is a crucial step and several aspects need to be considered for successful clinical trials. […]

    Welcome to MVA Oncology Network and our 7th meeting – Oncology Animal Models Oncology is one of the leading areas of research resulting in new therapeutics. Due to the challenges inherent in researching and developing anticancer therapeutics, predictive and robust preclinical models and approaches are critical. Medicon Valley Alliance, together with one of our members […]

  Welcome to MVA Oncology Network and our 6th meeting – an investor pitch evening! Medicon Valley Alliance Oncology Network set up by prof. and entrepreneur  Nils Brünner (University of Copenhagen) and prof. and entrepreneur Carl Borrebaeck, (Lund University) has now been up and running for two year. To celebrate these succesful years, Medicon Valley Alliance, together […]

    Welcome to MVA Oncology Network and our 5th meeting! Biomarkers – opportunities and challenges in oncology drug development Biomarker measurements have become an essential component of oncology drug development, particularly so in this era of targeted therapies. What does it take to get a biomarker from discovery to translation to commercialization? Are we making the most out […]

  Welcome to MVA Oncology Network and our 4th meeting – a pitch evening with Alligator Bioscience! Medicon Valley Alliance Oncology Network set up by prof. and entrepreneur  Nils Brünner (University of Copenhagen) and prof. and entrepreneur Carl Borrebaeck, (Lund University) has now been up and running for one year. To celebrate this first succesful year, […]

Welcome to MVA Oncology Network and our 3rd meeting! The interest in joining the Medicon Valley Alliance Oncology Network set up by prof. and entrepreneur  Nils Brünner (University of Copenhagen) and prof. and entrepreneur Carl Borrebaeck, (Lund University) is still on the rise. Medicon Valley Alliance, together with two of our members – the science parks Medeon […]

Welcome to MVA Oncology Network and our 2nd meeting! Genmab is on everybody’s lips. Why is that and how did it come about? Medicon Valley Alliance member, Genmab, has a story to tell that is worth listening to for everybody interested in business and life science innovation in general and oncology in particular. That is […]

Welcome to the MVA Oncology Network! Several members of Medicon Valley Alliance working with oncology have aired an interest in a forum for more specific professional and social networking within oncology. A group of members decided to explore this interest further and the idea of an MVA Oncology Network was born! The idea is to initiate an […]